![Frontiers | Extrafollicular Plasmablasts Present in the Acute Phase of Infections Express High Levels of PD-L1 and Are Able to Limit T Cell Response Frontiers | Extrafollicular Plasmablasts Present in the Acute Phase of Infections Express High Levels of PD-L1 and Are Able to Limit T Cell Response](https://www.frontiersin.org/files/Articles/828734/fimmu-13-828734-HTML-r1/image_m/fimmu-13-828734-g001.jpg)
Frontiers | Extrafollicular Plasmablasts Present in the Acute Phase of Infections Express High Levels of PD-L1 and Are Able to Limit T Cell Response
![Frontiers | Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19 Frontiers | Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19](https://www.frontiersin.org/files/Articles/899617/fimmu-13-899617-HTML-r1/image_m/fimmu-13-899617-g001.jpg)
Frontiers | Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19
![DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors | ACS Medicinal Chemistry Letters DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors | ACS Medicinal Chemistry Letters](https://pubs.acs.org/cms/10.1021/acsmedchemlett.9b00093/asset/images/large/ml-2019-00093k_0006.jpeg)